Company identity
Company number 07426406
Company profile
UK company 07426406, incorporated on 2 November 2010.
AI-Powered Imaging Biomarkers for Better Treatment | Radiology AI
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Company number 07426406
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Jan 2024 to 30 Jun 2025
Rapid diagnosis and treatment of stroke is critical in improving outcomes for stroke, which is the leading cause of serious long-term disability globally. Stroke is the fourth largest cause of death in the UK and costs £25.6 billion annually. The most common type of stroke is a large vessel occlusion which is a clot lodged in a major artery in the brain. ...
1 Jan 2019 to 31 Mar 2023
"We have formed a consortium of collaborating hospitals and commercial companies with public and patient involvement and input from charities to enable us to work with the public and the NHS to best develop and test the use of Artificial Intelligence programmes to improve health care. We are working with university academics and NHS hospitals across the c...
1 Oct 2015 to 30 Sep 2017
Worldwide annually, 13,000,000 patients suffer a stroke. Mechanical clot removal (endovascular treatment) is expected to increase from 1% to 10% of patients, as recent studies show it improves patient outcome. It costs up to £23,000 per patient, making patient selection crucial for its adoption. Brainomix has developed the medical imaging software, e-ASPE...
1 Sep 2013 to 31 Mar 2015
Stroke is the third cause of death and the first cause of adult disability in the UK. Each year, there are about 110,000 strokes in the UK, 1 million in the European Union and 15 million worldwide. For the NHS, the direct and indirect costs amount to £9 billion. The majority of strokes (~90%) are ischaemic and caused by an occlusion of a brain artery. The...
1 Sep 2012 to 28 Feb 2013
Awaiting Public Project Summary